Publication | Closed Access

Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins

MedicineHuntington Disease PatientsBrain Glucose HypometabolismNeuropharmacologyNeurochemical BiomarkersNeuroprotectionNeuroscienceNeurologyNeurodegenerationNeuropathologyPharmacology